Cost Effectiveness of Insulin Degludec Plus Liraglutide (IDegLira) in a Fixed Combination for Uncontrolled Type 2 Diabetes Mellitus in Sweden
Applied Health Economics and Health Policy - Switzerland
doi 10.1007/s40258-016-0301-y
Full Text
Open PDFAbstract
Available in full text
Date
January 6, 2017
Authors
Publisher
Springer Science and Business Media LLC